José Oliva Montero

José Oliva Montero
  • PostDoc Position at Karolinska Institutet

About

5
Publications
2,300
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
81
Citations
Current institution
Karolinska Institutet
Current position
  • PostDoc Position
Additional affiliations
June 2019 - present
Karolinska Institutet
Position
  • PostDoc Position
Description
  • Postdoctoral Studies in biomedical engineering-based approaches in neurooncology
February 2012 - March 2018
Pablo de Olavide University
Position
  • PhD Student
Description
  • Nanosystem developer in cancer diseases. Diagnostic and treatment.
Education
January 2012 - March 2018
Pablo de Olavide University
Field of study
  • Nanomedicine
November 2011 - September 2012
Pablo de Olavide University
Field of study
  • Materials Science
February 2009 - June 2012
University of Seville
Field of study
  • Biochemistry

Publications

Publications (5)
Article
Malignancies such as lung, breast and pancreatic carcinomas are associated with increased expression of the epidermal growth factor receptor, EGFR, and its role in the pathogenesis and progression of tumors has made this receptor a prime target in the development of antitumor therapies. In therapies targeting EGFR, the development of resistance owi...
Article
Full-text available
Progress in the field of biocompatible SERS nanoparticles has promising prospects for biomedical applications. In this work, we have developed a biocompatible Raman probe by combining anisotropic silver nanoparticles with the dye rhodamine 6G followed by subsequent coating with bovine serum albumin. This nanosystem presents strong SERS capabilities...
Article
Full-text available
Silver nanoparticles offer a huge potential for biomedical applications owing to their exceptional properties and small size. Specifically, cysteamine-capped silver nanoparticles could form the basis for new anticancer therapies combining the cytotoxic effect of the silver core with the inherent antitumor activity of cysteamine, which inhibit cance...
Article
Tannic acid (TA) has multiple effects against cancer, being especially promising in those types that overexpress the epidermal growth factor receptor (EGFR), as TA modulates its activation and downstream signaling pathways, triggering apoptosis. Nonetheless, despite the important role of this receptor in the pathogenesis and progression of a wide v...

Network

Cited By